Moderna Inc. will provide as many as 100 million doses of COVID-19 shots that specifically target variants for vaccine alliance GAVI to distribute in lower-income countries in 2023. Under the agreement, Moderna will supply these mRNA variant-targeting shots for...
China and Hong Kong have become the new focal point of the latest COVID-19 surge. China is enduring its first big outbreak of the Omicron variant and its “zero COVID” policy is bringing more pain with little gain. The...
